IGF-1 Monitoring on TRT: Essential for Optimal Health

Last Updated: OCTOBER 2023

Men with total testosterone below 300 ng/dL face a significant health burden, including increased cardiovascular risk. Specifically, a landmark study published in the Journal of Clinical Endocrinology & Metabolism in 2018 reported that men with total testosterone levels below 300 ng/dL had 2.4 times higher cardiovascular mortality compared to those with higher levels. Optimizing hormonal balance extends beyond testosterone itself, encompassing a complex interplay with other critical endocrine systems, notably the growth hormone (GH) and insulin-like growth factor-1 (IGF-1) axis. For men on Testosterone Replacement Therapy (TRT), understanding and monitoring IGF-1 levels is crucial for truly comprehensive health optimization, impacting everything from body composition to metabolic health and neurological function.

Understanding the Growth Hormone-IGF-1 Axis

The growth hormone-insulin-like growth factor-1 (GH-IGF-1) axis is a vital endocrine pathway regulating growth, metabolism, and body composition throughout life. Growth hormone, produced by the pituitary gland, is released in pulsatile bursts, primarily during sleep and intense exercise. GH itself has some direct effects, but its most profound actions are mediated by IGF-1.

IGF-1 is a polypeptide hormone primarily synthesized in the liver, but also in other tissues, in response to GH stimulation. Once released, IGF-1 circulates through the bloodstream, largely bound to IGF binding proteins (IGFBPs), which regulate its bioavailability. IGF-1 acts on a wide array of tissues, promoting cell proliferation, differentiation, and survival. It plays a critical role in muscle protein synthesis, bone density maintenance, fat metabolism, and even neurological health. Optimal IGF-1 levels are generally associated with better body composition, improved insulin sensitivity, and overall vitality.

Normal IGF-1 levels are highly age-dependent, typically peaking in puberty and gradually declining with age. Reference ranges for IGF-1 vary significantly between laboratories due to different assay methods, but generally, a healthy adult male might see ranges such as 100-300 ng/mL, with optimal levels often targeted in the upper-mid range for men on TRT, adjusted for age.

Testosterone’s Influence on the GH-IGF-1 Axis

Testosterone is not an isolated hormone; it profoundly interacts with other endocrine systems. Evidence shows a clear link between testosterone status and the GH-IGF-1 axis. Testosterone can stimulate both the secretion of growth hormone and the liver’s production of IGF-1.

Clinical studies have demonstrated this interaction. For instance, a study by Veldhuis et al. (2005) published in the Journal of Clinical Endocrinology & Metabolism found that “Testosterone replacement therapy increases insulin-like growth factor-1 in hypogonadal men without affecting growth hormone pulsatility.” This indicates that even if the pulsatile release of GH might not significantly change, testosterone’s presence enhances the overall activity of the axis, likely by increasing the sensitivity of tissues (especially the liver) to GH or directly promoting IGF-1 synthesis.

For men undergoing TRT, this means that optimizing testosterone levels can indirectly lead to more favorable IGF-1 concentrations. This synergy is particularly beneficial for body composition, as higher IGF-1 levels support muscle mass accretion and reduce fat mass, complementing the direct anabolic effects of testosterone.

Why Monitor IGF-1 on TRT?

Monitoring IGF-1 on TRT provides a more complete picture of a man’s anabolic and metabolic health beyond just testosterone levels. It’s a key biomarker for several reasons:

• Anabolic Environment: IGF-1 is a powerful anabolic hormone. Tracking it helps confirm if the body is in an optimal state for muscle growth and recovery, particularly relevant for men prioritizing strength and physique.
• Bone Health: IGF-1 plays a critical role in bone metabolism. Healthy levels support bone density, reducing the risk of osteoporosis, which can be a concern with age.
• Metabolic Health: IGF-1 influences insulin sensitivity and glucose metabolism. Monitoring it can provide insights into metabolic efficiency and risk for conditions like type 2 diabetes.
• Pituitary Function: Persistently low IGF-1, even with optimized testosterone, could signal an underlying issue with growth hormone production from the pituitary gland, known as Adult Growth Hormone Deficiency (AGHD). This requires further investigation.
• Liver Health: Since the liver is the primary site of IGF-1 production, significantly low IGF-1 levels could also indicate compromised liver function, prompting further diagnostic testing.

As stated in a systematic review on IGF-1 as a biomarker for health, “IGF-1 serves as a key mediator of growth hormone actions, playing a pivotal role in cell proliferation, differentiation, and metabolism throughout life” (Scherer et al., Journal of Clinical Endocrinology & Metabolism, 2019). This underscores its widespread physiological importance.

Interpreting IGF-1 Results on TRT

When on TRT, your IGF-1 levels should ideally be within the healthy, age-appropriate range, often trending towards the upper-middle portion of that range.

Understanding the Numbers